Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 124.575 USD -2.41% Market Closed
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jazz Pharmaceuticals PLC
Accounts Payable Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Accounts Payable
$85.4m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
11%
Perrigo Company PLC
NYSE:PRGO
Accounts Payable
$458.5m
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
4%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Accounts Payable
$9.8m
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
5%
G
GH Research PLC
NASDAQ:GHRS
Accounts Payable
$3.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Accounts Payable
€14.7m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
8%
Ovoca Bio PLC
LSE:OVB
Accounts Payable
€451k
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
2%

See Also

What is Jazz Pharmaceuticals PLC's Accounts Payable?
Accounts Payable
85.4m USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Accounts Payable amounts to 85.4m USD.

What is Jazz Pharmaceuticals PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
11%

Over the last year, the Accounts Payable growth was -22%. The average annual Accounts Payable growth rates for Jazz Pharmaceuticals PLC have been 10% over the past three years , 4% over the past five years , and 11% over the past ten years .

Back to Top